In this session, Mohamed Sorror, MD, MSc; Fred Hutchinson Cancer Research Center, will cover:

• Diseases for which HCT is an option
• Patient populations (peds, AYA, older pts)
• Donor sources – auto, related and unrelated allo
• Graft sources – PBSC, BM, Cord blood
• HLA typing
• Assessing transplant readiness
• Co-morbidity score and impact on treatment related mortality
• Transplant timeline (conditioning, product infusion, supportive care including transfusions/growth factors, engraftment)
• Maintenance therapy

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Rebecca Gonzalez, PharmD, BCOP; Moffitt Cancer Center. The event aired on Thursday, June 8, 2023.

By the end of this session, learners will be able to:

•Summarize similarities and differences in conditioning regimens
•Review conditioning agents and their unique toxicity profiles and dose-limiting toxicities (DLT)
•Evaluate the different graft versus host disease (GVHD) immunosuppression prophylaxis options

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Nelson Chao, MD; Duke University. The event aired on Thursday, June 8, 2023.

By the end of this session, learners will be able to:

• Describe the reason for developing GVHD
• Name first and second line treatments

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Jaime A. Suarez Londono, MD; NYU Langone Health. The event aired on Thursday, June 8, 2023.

By the end of this session, learners will be able to:

• Review the most common, non-infectious  complications of stem cell transplantation by organ system
• Understand the physiopathology of the non-infectious complications of stem cell transplantation
• Discuss preventive and treatment strategies for non-infectious  complications of stem cell transplantation

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Danniel Zamora, MD; Fred Hutchinson Cancer Research Center. The event aired on Thursday, June 8, 2023.

This presentation will cover the following topics:

•Infections after hematopoietic cell transplantation (HCT).
   -Epidemiology and risk factors.
   -Changes in practice over time.
   -Case-based examples.
•Infections after novel cellular therapies.
   -Emphasis on CD19 and B-cell maturation antigen (BCMA)-targeted CAR-T Cell therapies.
•COVID-19.

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Catherine Lee, MD; Fred Hutchinson Cancer Research Center. The event aired on Friday, June 9, 2023.

By the end of this session, learners will be able to:

• Understand the importance of survivorship in the continuum of HCT treatment
• Describe common late effects of HCT and how they affect quality of life
• Discuss the role of patient-reported outcome measures in the clinical care of patients and in survivorship research 
• Identify essential components of high-quality survivorship and late effects care for children and adults

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording of the panel session presented live at the 2023 Clinical Immersion Course. The event aired on Friday, June 9, 2023.

The panel discussion covered: 

• Multidisciplinary care team – roles and responsibilities
• Value of pharmaceutical representation and drug programs
• Role of other subspecialties in patient care

Moderator:

• Mariana Lucena, PharmD, BCOP; Incyte 

Panel Faculty:

• Physician Panelist: Marc Braunstein, MD; NYU Langone Health
• Pharmacy Panelist: Elizabeth DiMaggio, PharmD, BCOP, Moffitt Cancer Center
• APP Panelist: Misty Evans, DNP, APRN, CPNP-AC; Vanderbilt University
• Social Work Panelist: Katie Schoeppner, MSW, LICSW; National Marrow Donor Program
• Patient Panelist: Rebecca Dame

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Amy Moskop, MD; Center for International Blood and Marrow Transplant Research. The event aired on Friday, June 9, 2023.

Dr. Moskop will cover the following topics:

• Basics of CAR T-cell therapy
• FDA approved Indications for CAR T cell therapy
• Industry Partnership
• Overview of CIBMTR Cellular Therapy Registry
• Real World Experience

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Tania Jain, MD; Johns Hopkins Medicine. The event aired on Friday, June 9, 2023.

This session will cover the following topics:

• Mechanism and distinct processes of TIL, TCR
• Data from clinical studies for TIL, TCR
• Mechanism of BiTE therapy
• Clinical studies, responses, and challenges with BiTE

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.

This is the recording and slides of the session presented live at the 2023 Clinical Immersion Course by Michael Jain, MD; Moffitt Cancer Center. The event aired on Friday, June 9, 2023.

This session will cover the following topics: 

• Overview of CAR T-cell therapy
• Cytokine release syndrome
• Neurologic Toxicities
• Cytopenias and Infections
• Second Malignancies

The Clinical Immersion Course package is only accessible for those who attended the live course or that purchased the package after the live course. Resale or sharing of this content is prohibited.